Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

11:25 AM - 11:35 AM PT

203 - Mechanisms of Acquired Radioresistance in Diffuse Large B-Cell Lymphoma
Speaker: Troschel, Fabian, MD - Muenster University, Muenster, Nordrhein-Westfa
11:25 AM - 11:35 AM PT

208 - Prevention of Myelosuppression Associated with Concurrent Chemoradiotherapy in Limited Stage Small Cell Lung Cancer
Speaker: Liu, Chang, PhD - Peking University International Hospital, Beijing
11:25 AM - 11:35 AM PT

215 - Prognostic Nutritional Index as a Prognostic Factor in Stage IV Lung Cancer Patients Receiving Palliative Radiation Therapy
Speaker: Tanaka, Hidekazu, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi
11:25 AM - 11:35 AM PT

220 - Direct-to-Unit Stereotactic Body Radiation Therapy Utilizing Adaptive Planning
Speaker: Sharifzadeh, Yasamin, MD - Mayo Clinic Rochester, Rochester, MN
11:25 AM - 11:35 AM PT

227 - Osteoclast-Neuron Crosstalk Drives Radiation-Induced Pain
Speaker: Park, Sun, PhD - Wake Forest School of Medicine, Winston-Salem, NC
11:25 AM - 11:35 AM PT

233 - Early Prediction of Radiotherapy Outcome Using ADC Metrics for Head & Neck Squamous Cell Carcinoma
Speaker: McDonald, Brigid, PhD - MD Anderson Cancer Center, Houston, TX
11:35 AM - 11:45 AM PT

198 - Patient-Reported Outcomes in a Randomized Trial of <sup>18</sup>F-Fluciclovine vs<sup>68</sup>Ga-PSMA-11 PET/CT-Guided Post-Prostatectomy Radiation with Simultaneous Integrated Boosts
Speaker: Jani, Ashesh, MD, MS, FASTRO - Emory University, Atlanta, GA
11:35 AM - 11:45 AM PT

210 - Analysis of Progressive Patterns after First-Line Chemoimmunotherapy with or without Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
Speaker: Li, Butuo, MD, MB, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong
11:35 AM - 11:45 AM PT

221 - Feasibility of Moderately Hypofractionated Online Adaptive Radiotherapy in the Treatment of Cervical Cancer
Speaker: Zeng, Zheng, MD - Peking Union Medical College Hospital, Beijing, Beijing
11:35 AM - 11:45 AM PT

228 - Impact of Radiotherapy Site, Modality, and Dose on Subsequent Clonal Hematopoiesis
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
11:35 AM - 11:45 AM PT

234 - Quantitative Parameters Derived from Dual Energy CT and Hematological Features Predict Pathological Complete Response in Neoadjuvant Chemoradiotherapy Esophageal Squamous Cell Carcinoma Patients
Speaker: Cui, Yongbin, PhD - Shandong Cancer Hospital and Institute, Jinan, Shandong
11:35 AM - 11:45 AM PT

Discussant
Speaker: Kelsey, Christopher, MD, FASTRO - Duke University Medical Center, Durham, North Carolina